SEC Form 4 · accession 0001415889-19-000052
Vistagen Therapeutics, Inc. · VTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shawn Singh
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jan 14, 2019
Accepted (ET)
Jan 14, 2019 · 9:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411685
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.70 | Jan 14, 2019 | A | 220,000 | A | — | Jan 14, 2029 | Common Stock | 220,000 | 220,000 | D |
Explanation of responses
- F125% of the shares subject to the Option reported herein shall vest on the Vesting Start Date of January 14, 2019, and 1/24th of the remaining shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter.